Loading clinical trials...

A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports | Clinical Trials | Clareo Health

UNKNOWN

A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports

NCT05519761•Perouse Medical

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate performance and safety of POLYSITE® and SEESITE® implantable ports allowing repeated and prolonged access to the venous system for the administration of chemotherapy, antibiotics, antiviral drugs, parenteral nutrition, and for blood transfusion or blood derivatives transfusion.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adult and paediatric population
•Patient who received the implantation of any POLYSITE® or SEESITE® implantable port referenced in the Annex 1 of the current protocol between 1-JAN-2018 and 31-DEC-2020

Exclusion Criteria

•Patient who refused the data collection according to GDPR regulation applicable in France
•Patient who received the implantation of another device than those presented in Annex 1 of the current protocol.

Locations (3)

CHR d'Orléans

Orléans, France

Hopital Foch

Suresnes, France

IGR

Villejuif, France

Key Dates

Start Date

March 15, 2022

Primary Completion Date

October 30, 2022

Completion Date

October 30, 2022

Last Updated

August 29, 2022

Enrollment

250

ESTIMATED participants

Conditions

VeinousChemotherapyAntibioticsAntiviral DrugsParenteral NutritionBlood TransfusionBlood Derivatives TransfusionPMCF Study

Interventions

Implantation of veinous access ports

DEVICE

Contacts

Chems Hachani, CEO

CONTACT

33 699150368 chachani@eclevar.com

Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy

NCT07423390

Peripheral Neuropathy Due to ChemotherapyPeripheral Neuropathy, Chemotherapy-induced

View study

RECRUITINGNA

Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients

NCT07435597

Oncologic DiseaseChemotherapy

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 29, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports

Inclusion Criteria

Exclusion Criteria

Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy

Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients

Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy